Drug Profile
Research programme: ORAI1 protein modulators - QUE Oncology
Alternative Names: Q-202Latest Information Update: 28 Jul 2020
Price :
$50
*
At a glance
- Originator QUE Oncology
- Class
- Mechanism of Action ORAI1 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 28 Jul 2020 No recent reports of development identified for research development in Breast-cancer in USA
- 07 Jun 2016 Early research in Breast cancer in USA (unspecified route) before June 2016